Related Experiment Videos
Increased bone metabolism in a patient undergoing long-term rhG-CSF treatment for idiopathic acquired neutropenia
U J Woermann1, R Schenk, A Zimmermann
1Central Hematology Laboratory, University of Bern, Inselspital, Switzerland.
Annals of Hematology
|May 1, 1993
Abstract:
Recombinant human granulocyte colony-stimulating factor (rhG-CSF) has been used mainly for treatment of chemotherapy-induced neutropenia. The reported side effects were of minor importance. We describe a case of long-term treatment with rhG-CSF, in which we observed enhanced bone remodeling.